Evaxion Biotech A/S (EVAX) Ownership
EVAX ownership summary
as of October 18, 2026- Institutions
- 9.4% of shares outstanding
- Insiders
- 16.15% of shares outstanding
- Shares outstanding
- 9.0M
- Float
- 5.7M shares available to trade
- Short interest
- 0.67% 51K shares short
- Days to cover
- 1.06 short interest down 6.0% vs prior month
- Institutions 9.42%
- Insiders 16.15%
- Other investors 74.43%
EVAX top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Merck & Co Inc | 13.46% | 1.2M | $3.4M | +1.2M (0.0%) | June 30, 2026 |
| 2 | Ikarian Capital, LLC | 0.83% | 75K | $211,395 | — | June 30, 2026 |
| 3 | Rathbone Brothers PLC | 0.51% | 46K | $129,396 | −45,723 (−50.0%) | June 30, 2026 |
| 4 | Citadel Advisors Llc | 0.41% | 37K | $103,533 | +18,811 (+105.8%) | June 30, 2026 |
| 5 | Renaissance Technologies Corp | 0.37% | 34K | $95,654 | −5,425 (−13.8%) | June 30, 2026 |
| 6 | Annis Gardner Whiting Capital Advisors LLC | 0.33% | 30K | $84,900 | — | June 30, 2026 |
| 7 | J. Safra Sarasin Holding AG | 0.25% | 23K | $64,796 | +22,896 (0.0%) | June 30, 2026 |
| 8 | Rhumbline Advisers | 0.24% | 22K | $61,833 | +190 (+0.9%) | June 30, 2026 |
| 9 | Jane Street Group LLC | 0.23% | 21K | $58,244 | +20,581 (0.0%) | June 30, 2026 |
| 10 | BOOTHBAY FUND MANAGEMENT, LLC | 0.20% | 18K | $52,146 | — | June 30, 2026 |
| 11 | Stonepine Capital Management Llc | 0.19% | 18K | $49,700 | −2,151 (−10.9%) | June 30, 2026 |
| 12 | SmartHarvest Portfolios, LLC | 0.15% | 13K | $38,092 | −348 (−2.5%) | June 30, 2026 |
| 13 | XTX Topco Ltd | 0.14% | 13K | $36,504 | −9,154 (−41.5%) | June 30, 2026 |
| 14 | WesBanco Bank Inc | 0.11% | 10K | $28,300 | — | June 30, 2026 |
| 15 | Northwestern Mutual Wealth Management Co | 0.09% | 8,000 | $22,640 | — | June 30, 2026 |
| 16 | UBS Group AG | 0.07% | 6,275 | $17,758 | +6,275 (0.0%) | June 30, 2026 |
| 17 | GAMMA Investing LLC | 0.05% | 4,612 | $13,052 | −586 (−11.3%) | June 30, 2026 |
| 18 | Integrated Wealth Concepts LLC | 0.01% | 642 | $1,817 | +642 (0.0%) | June 30, 2026 |
| 19 | SBI Securities Co Ltd | <0.01% | 62 | $175 | — | June 30, 2026 |
| 20 | Bessemer Group Inc | <0.01% | 18 | $51 | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 7 holders added 1.3M shares and 6 cut 63K.
EVAX top mutual fund and ETF holders
2 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | PSM Macro Strategy | 0.92% | 83K | $235,756 | +11,000 (+15.2%) | August 31, 2026 |
| 2 | PSM Value Strategy UI | 0.89% | 80K | $226,256 | — | May 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
EVAX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns EVAX
Institutional investors own 9.4% of Evaxion Biotech A/S's shares and insiders 16.15%. The largest holder is Merck & Co Inc with 13.46% of the shares (1.2M), as of June 30, 2026. Among the top 20 institutions, 7 added shares and 6 reduced their stake in the latest filings. Short interest is 0.67% of the float, or 1.06 days of average trading volume. The share count rose 1,235.0% since 2019.
Related: EVAX analyst forecast, EVAX key metrics. See the EVAX stock overview for the latest quote and news.
EVAX ownership FAQ
Who owns the most Evaxion Biotech A/S stock?
The largest shareholders of Evaxion Biotech A/S are Merck & Co Inc (13.46%), Ikarian Capital, LLC (0.83%), Rathbone Brothers PLC (0.51%), Citadel Advisors Llc (0.41%), Renaissance Technologies Corp (0.37%).
What percentage of Evaxion Biotech A/S is owned by institutions?
Institutions hold 9.4% of Evaxion Biotech A/S's shares outstanding; insiders hold 16.15%.
Which funds own Evaxion Biotech A/S?
The largest fund holders of Evaxion Biotech A/S are PSM Macro Strategy (0.92%), PSM Value Strategy UI (0.89%).
What is Evaxion Biotech A/S's short interest?
51K shares of Evaxion Biotech A/S were sold short, 0.67% of the float; at the average daily volume it would take 1.06 days to cover.
How many shares of Evaxion Biotech A/S are outstanding?
Evaxion Biotech A/S has 9.0M shares outstanding, of which 5.7M are in the public float.